Are patents on genes really patents on innovations? What should be patentable? Should organisations ‘own’ exclusive rights to human genetic information? How would researchers attract the investment needed to fund research if the patenting environment were to change? How do we ensure that society continues to benefit from research which may lead to accessible tests and treatments?
These questions and more will be discussed at a small-scale workshop to discuss gene patenting in the Australian context.
Dr Robert Chalmers, ARI, University of Adelaide
Professor Dianne Nichol, Faculty of Law, University of Tasmania
Professor Ian Olver AM, CEO, Cancer Council of Australia
Dr Luigi Palombi, Intellectual Property Law Consultant
Ms Melissa Parke MP, Federal Member for Fremantle
Facilitator: Associate Professor Rachel Ankeny, University of Adelaide
When: Friday October 26 from 1.30 pm to 5.30 pm (refreshments from 4.45pm)
Where: B03 Seminar Room West, Masonic Lodge, North Terrace